Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating Expenses:        
Research and development $ 488,323 $ 789,441 $ 853,509 $ 1,367,750
Research and development - related parties 133,665 131,463 304,207 348,147
General and administrative 1,224,750 2,762,076 2,781,490 6,770,928
Total Operating Expenses 1,846,738 3,682,980 3,939,206 8,486,825
Loss From Operations (1,846,738) (3,682,980) (3,939,206) (8,486,825)
Other (Expense) Income:        
Other Income 1,712,702 2,752,066
Interest expense (11,360) (11,606) (27,809) (23,162)
Change in fair value of derivative liabilities 249 14,417 58 67,740
Gain on settlement of liabilities 156,928 156,928
Total other (expense) income, net 1,858,519 2,811 2,881,243 44,578
Income (Loss) Before Income Taxes 11,781 (3,680,169) (1,057,963) (8,442,247)
Income tax benefit
Net Income (Loss) 11,781 (3,680,169) (1,057,963) (8,442,247)
Other Comprehensive Income (Loss):        
Foreign currency translation adjustments (20,861) (15,267) (14,401) (14,604)
Total Comprehensive Income (Loss) $ (9,080) $ (3,695,436) $ (1,072,364) $ (8,456,851)
Basic and Diluted Net Income (Loss) per Common Share        
Basic (in Dollars per share) $ 0.01 $ (13.37) $ (1.42) $ (42.81)
Diluted (in Dollars per share) $ 0.01 $ (13.37) $ (1.42) $ (42.81)
Weighted Average Number of Common Shares Outstanding:        
Basic (in Shares) 919,141 275,332 745,552 197,219
Diluted (in Shares) 919,141 275,332 745,552 197,219